These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 14836949)
1. [Clinical evaluation of spirotrypan, a new arsenobenzol preparation]. FOLSCH F; GLASER J; KRIEGK HJ Z Haut Geschlechtskr; 1951 Apr; 10(7):288-92. PubMed ID: 14836949 [No Abstract] [Full Text] [Related]
2. [Spirotrypan, a new arsenobenzol preparation in syphilis therapy]. SIEBERT G Med Klin; 1953 Aug; 48(32):1158-9. PubMed ID: 13086419 [No Abstract] [Full Text] [Related]
3. [Clinical experiences with the new arsenobenzol preparation spirotrypan]. HEITE HJ; HULSBRINK H Dtsch Med Wochenschr; 1953 Apr; 78(17):643-6. PubMed ID: 13067950 [No Abstract] [Full Text] [Related]
4. [Experiences with the arsenobenzene preparation Spirotrypan (Hoechst) in syphilis]. LEDIG R Dermatol Wochenschr; 1952; 125(21):481-5. PubMed ID: 14954735 [No Abstract] [Full Text] [Related]
5. [Clinical and serological experiences in treatment of syphilis with spirotrypan]. THELEN K Z Haut Geschlechtskr; 1953 Aug; 15(4):126-30. PubMed ID: 13103281 [No Abstract] [Full Text] [Related]
6. [Syphilis therapy with spirotrypan]. SCHWARZKOPF K Z Haut Geschlechtskr; 1953 Feb; 14(3):87-9. PubMed ID: 13078900 [No Abstract] [Full Text] [Related]
8. [The chemotherapeutic effects of certain oil-soluble organomercuric compounds, of ebesal and of spirotrypan on experimental syphilis in rabbits]. SCHLOSSBERGER H; BRANDIS H Dermatol Wochenschr; 1953; 127(18):427-30. PubMed ID: 13067679 [No Abstract] [Full Text] [Related]
9. [Treatment of metaluetic diseases with spirotrypan]. BROBEIL A; HARTER O Med Klin; 1953 Jun; 48(26):928-32. PubMed ID: 13086326 [No Abstract] [Full Text] [Related]
10. [Resorption and excretion of spirotrypan, a new antiluetic of arsphenamine group]. HERMANN W; THER L Arch Dermatol Syph; 1953; 195(6):670-85. PubMed ID: 13105301 [No Abstract] [Full Text] [Related]
12. [Chemotherapeutic investigations on spirotrypan]. WAGNER WH; SCHULZ W Z Gesamte Exp Med; 1952; 119(2):204-28. PubMed ID: 12995716 [No Abstract] [Full Text] [Related]
13. [Lesions in syphilis treatment with arsenobenzol; indications and contraindications in therapy]. FOLDVARI F Orv Hetil; 1951 Jul; 92(28):892-9. PubMed ID: 14863886 [No Abstract] [Full Text] [Related]
14. Comparison of the spirocheticidal activity of arsphenamines and phenarsines (arsenoxides) in experimental syphilis. PROBEY TF Public Health Rep (1896); 1947 Jul; 62(29):1041-8. PubMed ID: 20344054 [No Abstract] [Full Text] [Related]
15. [Experimental and clinical studies on the use of arsenobenzol and bismuth in the penicillin therapy of syphilis]. MONCORPS ; HEITE Arch Dermatol Syph; 1950; 191():446-50. PubMed ID: 14790651 [No Abstract] [Full Text] [Related]
16. [Tolerance of spirotrypan]. JANSSON H Hautarzt; 1952 Oct; 3(10):464-5. PubMed ID: 13010650 [No Abstract] [Full Text] [Related]
18. Penicillin-arsenoxide-bismuth treatment of early syphilis; follow-up of patients treated in 1947 in Oslo Municipal Hospital. GUNDERSEN H Acta Derm Venereol; 1950; 30(5):442-4. PubMed ID: 14789416 [No Abstract] [Full Text] [Related]
19. [Studies on jaundice due to arsenobenzol]. GRANA A Rass Dermatol Sifilogr; 1952; 5(5):279-86. PubMed ID: 13064418 [No Abstract] [Full Text] [Related]
20. [Considerations of the combination therapy with penicillin preparations of arsenobenzol and bismuth in the treatment of syphilis]. CERUTTI P Resen Clin Cient; 1956; 25(3-4):87-8. PubMed ID: 13350612 [No Abstract] [Full Text] [Related] [Next] [New Search]